Galenica Sante Ag Stock Price To Earning
GALE Stock | CHF 70.55 0.55 0.79% |
Galenica Sante AG fundamentals help investors to digest information that contributes to Galenica Sante's financial success or failures. It also enables traders to predict the movement of Galenica Stock. The fundamental analysis module provides a way to measure Galenica Sante's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Galenica Sante stock.
Galenica |
Galenica Sante AG Company Price To Earning Analysis
Galenica Sante's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Galenica Sante Price To Earning | 16.37 X |
Most of Galenica Sante's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Galenica Sante AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition |
Based on the latest financial disclosure, Galenica Sante AG has a Price To Earning of 16.37 times. This is 36.65% lower than that of the Healthcare sector and 232.05% higher than that of the Biotechnology industry. The price to earning for all Switzerland stocks is 43.0% higher than that of the company.
Galenica Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Galenica Sante's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Galenica Sante could also be used in its relative valuation, which is a method of valuing Galenica Sante by comparing valuation metrics of similar companies.Galenica Sante is currently under evaluation in price to earning category among related companies.
Galenica Fundamentals
Return On Equity | 0.15 | |||
Return On Asset | 0.0492 | |||
Profit Margin | 0.04 % | |||
Operating Margin | 0.05 % | |||
Current Valuation | 4.26 B | |||
Shares Outstanding | 49.64 M | |||
Shares Owned By Insiders | 0.17 % | |||
Shares Owned By Institutions | 49.77 % | |||
Price To Earning | 16.37 X | |||
Price To Book | 3.16 X | |||
Price To Sales | 0.94 X | |||
Revenue | 3.83 B | |||
Gross Profit | 427.92 M | |||
EBITDA | 305.98 M | |||
Net Income | 167.68 M | |||
Cash And Equivalents | 164.98 M | |||
Cash Per Share | 2.13 X | |||
Total Debt | 579.88 M | |||
Debt To Equity | 43.80 % | |||
Current Ratio | 1.77 X | |||
Book Value Per Share | 23.35 X | |||
Cash Flow From Operations | 333.1 M | |||
Earnings Per Share | 3.45 X | |||
Target Price | 70.0 | |||
Number Of Employees | 5.52 K | |||
Beta | 0.19 | |||
Market Capitalization | 3.74 B | |||
Total Asset | 2.57 B | |||
Z Score | 4.6 | |||
Annual Yield | 0.03 % | |||
Net Asset | 2.57 B | |||
Last Dividend Paid | 2.1 |
About Galenica Sante Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Galenica Sante AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Galenica Sante using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Galenica Sante AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Galenica Sante in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Galenica Sante's short interest history, or implied volatility extrapolated from Galenica Sante options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galenica Sante AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Galenica Stock analysis
When running Galenica Sante's price analysis, check to measure Galenica Sante's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galenica Sante is operating at the current time. Most of Galenica Sante's value examination focuses on studying past and present price action to predict the probability of Galenica Sante's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galenica Sante's price. Additionally, you may evaluate how the addition of Galenica Sante to your portfolios can decrease your overall portfolio volatility.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |